Volume 11 - Issue 6 - June 2003
Department
Coding and Billing
09/04/2008
Now that many of you are aware that the Medicare pay rates have finally been settled for 2003, you’re probably still scratching your head and wondering, What’s the bottom line? After months of Congressional juggling, fee schedule and...
Now that many of you are aware that the Medicare pay rates have finally been settled for 2003, you’re probably still scratching your head and wondering, What’s the bottom line? After months of Congressional juggling, fee schedule and...
Now that many of you are aware...
09/04/2008
The Dermatologist
Ethnic Skin and Hair
09/04/2008
Keloids are abnormal scars characterized by excessive scar tissue formation. Clinically, these elevated scars demonstrate extension beyond the original border of the wound. Hypertrophic scars differ from keloids in that they remain within the...
Keloids are abnormal scars characterized by excessive scar tissue formation. Clinically, these elevated scars demonstrate extension beyond the original border of the wound. Hypertrophic scars differ from keloids in that they remain within the...
Keloids are abnormal scars...
09/04/2008
The Dermatologist
09/04/2008
A team led by the National Human Genome Research Institute recently announced the discovery of the genetic basis of a disorder that causes the most dramatic form of premature aging. This finding will help shed light on the rare disease, as...
A team led by the National Human Genome Research Institute recently announced the discovery of the genetic basis of a disorder that causes the most dramatic form of premature aging. This finding will help shed light on the rare disease, as...
A team led by the National...
09/04/2008
The Dermatologist
09/04/2008
Imiquimod for AKs
3M, the manufacturer of imiquimod (Aldara) is seeking FDA approval for use of its drug to treat actinic keratosis. Already approved for treating genital warts, imiquimod has shown promise in treating AKs in clinical...
Imiquimod for AKs
3M, the manufacturer of imiquimod (Aldara) is seeking FDA approval for use of its drug to treat actinic keratosis. Already approved for treating genital warts, imiquimod has shown promise in treating AKs in clinical...
Imiquimod for AKs
3M, the...
09/04/2008
The Dermatologist
09/04/2008
Parents Stressed over Children’s Hemangiomas
A recent study reported that the parents of children with hemangiomas are more likely to experience emotional and psychological distress over their child’s condition than the children themselves....
Parents Stressed over Children’s Hemangiomas
A recent study reported that the parents of children with hemangiomas are more likely to experience emotional and psychological distress over their child’s condition than the children themselves....
Parents Stressed over...
09/04/2008
The Dermatologist
09/04/2008
The average cost of developing a new prescription drug is $897 million, almost four times the cost in the early 1990s, according to a study by the Tufts Center for the Study of Drug Development, Bloomberg/Bern Record reports. Results of the...
The average cost of developing a new prescription drug is $897 million, almost four times the cost in the early 1990s, according to a study by the Tufts Center for the Study of Drug Development, Bloomberg/Bern Record reports. Results of the...
The average cost of developing...
09/04/2008
The Dermatologist
09/04/2008
A recent study in the May 14 issue of the Journal of the American Medical Association reported that about 20% of American adults went online to search for heath information in 2001. Researchers from Stanford University conducted an online...
A recent study in the May 14 issue of the Journal of the American Medical Association reported that about 20% of American adults went online to search for heath information in 2001. Researchers from Stanford University conducted an online...
A recent study in the May 14...
09/04/2008
The Dermatologist
09/04/2008
I s dermatology today being drawn into two distinct camps? If so, the battle lines might be drawn this way: On one side sits a growing army of cosmetic/surgical dermatologists armed with lasers, Botox injections, and a cadre of patients happy...
I s dermatology today being drawn into two distinct camps? If so, the battle lines might be drawn this way: On one side sits a growing army of cosmetic/surgical dermatologists armed with lasers, Botox injections, and a cadre of patients happy...
I s dermatology today being...
09/04/2008
The Dermatologist
09/04/2008
Skin & Aging is proud to bring you this latest installment in its CME series. This series consists of regular CME activities that qualify you for two category 1 physician credit hours. As a reader of Skin & Aging, this course is...
Skin & Aging is proud to bring you this latest installment in its CME series. This series consists of regular CME activities that qualify you for two category 1 physician credit hours. As a reader of Skin & Aging, this course is...
Skin & Aging is proud to...
09/04/2008
The Dermatologist
Feature
Case Report and Brief Review
09/04/2008
Patient Presentation A 45-year-old Caucasian man presented with a 3-year history of asymptomatic whitish pebbly papules on the lobule of the right ear. Upon presentation, he was otherwise in a good health and was not taking any oral...
Patient Presentation A 45-year-old Caucasian man presented with a 3-year history of asymptomatic whitish pebbly papules on the lobule of the right ear. Upon presentation, he was otherwise in a good health and was not taking any oral...
Patient Presentation A...
09/04/2008
The Dermatologist
